Home » Topics » BioWorld Science

BioWorld Science
RSS

Sankyo discovers ACAT inhibitor

June 7, 1996

Hoescht reports imidobisphosphonic acid derivatives

June 7, 1996

Fujisawa claims ACAT inhibitors

June 7, 1996

InSite Vision and Ciba Vision marketing agreement for sustained-release eyedrop formulation

June 7, 1996

ISIS-5132/CGP-69846A efficacy reported in Nature Medicine

June 7, 1996

Indena claims colchicine derivatives

June 7, 1996

Manufacturing agreement for Neoprobe's RIGS/ACT activated cell therapy

June 7, 1996

E. Merck describes immunoconjugates

June 7, 1996

Melanogenesis inhibitor revealed

June 7, 1996

Ongoing evaluation of Pharmacia & Upjohn's new water-soluble camptothecin derivative

June 7, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...